CPT 54235 Intracavernosal Injection Reimbursement | OpenPayer

Summary & Overview

CPT 54235: Intracavernosal Pharmacologic Injection for Erectile Dysfunction

CPT code 54235 denotes an intracavernosal pharmacologic injection procedure used to treat erectile dysfunction by administering agents such as papaverine, phentolamine, or prostaglandin E1 into the corpora cavernosa. Nationally, this code captures a common outpatient therapeutic intervention for patients who have not responded to oral therapies or require diagnostic/therapeutic intracavernosal testing. Understanding billing and coverage patterns for this service matters because it affects access to specialty urologic care and informs payment policy for office- and ambulatory-based procedures.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find clinical context for when the procedure is used, typical sites of service, and how the code is defined for billing purposes. The publication provides benchmarks where available, notes on payer coverage considerations, and policy-relevant updates impacting coding and claims processing. Data not available in the input are identified clearly. This summary is intended to support revenue cycle, compliance, and clinical teams seeking a concise reference to the clinical intent and billing identity of CPT code 54235.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareCPT 54235intracavernosal injectionerectile dysfunctionurologyoutpatient procedurepharmacologic therapyprocedure codingmedical billingambulatory care

Billing Code Overview

CPT code 54235 describes injection of pharmacologic agents into the corpora cavernosa of the penis, using drugs such as papaverine, phentolamine, or prostaglandin E1, to treat erectile dysfunction. This procedure is a targeted intracavernosal pharmacologic therapeutic intervention.

Service type: Pharmacologic intracavernosal injection therapy
Typical site of service: Office, clinic, or ambulatory surgical center where outpatient erectile dysfunction treatments are administered

Clinical & Coding Specifications

Clinical Context

A 58-year-old male with a history of diabetes mellitus and coronary artery disease presents to the outpatient urology clinic with a 12-month history of persistent erectile dysfunction refractory to oral phosphodiesterase-5 inhibitors. After clinical evaluation, counseling on risks and benefits, and informed consent, the urologist performs intracavernosal injection therapy in clinic. The provider prepares a pharmacologic agent such as prostaglandin E1 (alprostadil) or a combination agent, cleans the penile shaft with antiseptic, identifies the lateral corpora cavernosa, and injects a measured dose into one corpus cavernosum. The patient is observed for immediate complications (pain, priapism, hematoma) for 15–30 minutes in the clinic, provided post-procedure instructions, and scheduled for follow-up to assess efficacy and possible repeat therapy or alternative interventions.

Coding Specifications

Modifier	Description	When to Use
`51`	Multiple procedures	Append when multiple distinct procedures are performed the same day in addition to the injection procedure.
`52`	Reduced services	Use when the intracavernosal injection is partially reduced or not performed to the full extent.

CPT 54240: Penile Plethysmography for Erectile Dysfunction Assessment

CPT-54220-IRRIGATION-OF-CORPORA-CAVERNOSA-PRIAPISM

CPT 54220: Irrigation of Corpora Cavernosa for Priapism

CPT-54230-CAVERNOSOGRAPHY-VENOUS-LEAKAGE-EVALUATION

CPT 54230: Cavernosography to Evaluate Venous Leakage

CPT-54231-DYNAMIC-CAVERNOSOMETRY-WITH-PHARMACOLOGIC-INJECTION

CPT 54231: Dynamic Cavernosometry with Pharmacologic Intracavernosal Injection

CPT-54200-PENILE-INJECTION-FOR-PEYRONIE-DISEASE

CPT 54200: Penile Injection for Peyronie Disease

CPT-54250-NOCTURNAL-PENILE-TUMESCENCE-NPT-MONITORING

CPT 54250: Nocturnal Penile Tumescence Monitoring

CPT-54205-PENILE-PLAQUE-EXPOSURE-AND-INJECTION-FOR-PEYRONIE-DISEASE

CPT 54205: Penile Plaque Exposure and Injection for Peyronie Disease

Taxonomy Code	Specialty	Notes
2084P0800X	Urology	Urologists most commonly perform intracavernosal injections.
208800000X	Family Medicine	Primary care physicians may administer injections in office for ED management.
207R00000X	Internal Medicine	Internists managing sexual dysfunction may perform or supervise injections.
2086S0123X	Physician Assistant	Mid-level providers frequently perform injections under physician supervision.
261QM2300X	Registered Nurse	Nurses often prepare and observe patients during office-based injection therapy.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`N52.9`	Erectile dysfunction, unspecified	Primary diagnosis for which intracavernosal injection therapy is indicated.
`E11.9`	Type 2 diabetes mellitus without complications	Common comorbidity contributing to vasculogenic erectile dysfunction.
`I25.10`	Atherosclerotic heart disease of native coronary artery without angina pectoris	Vascular disease associated with erectile dysfunction and treatment considerations.
`N48.4`	Peyronie disease	Structural penile disorder that may coexist with ED and influence treatment choice.
`F52.21`	Erectile disorder due to known physical condition	Used when ED is attributed to a specific physical condition and injections are part of management.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`54235`	Injection of pharmacologic agent into corporal body of penis	Primary procedure: intracavernosal pharmacologic injection for erectile dysfunction.
`54240`	Intra-corporal injection for diagnostic erection test	Diagnostic injection performed when assessing vascular causes of ED before therapeutic injections.
`54250`	Surgical correction of penile curvature (eg, Peyronie disease)	Performed when structural causes of ED are identified and surgical correction is required instead of injection therapy.
`54400`	Implantation of penile prosthesis, inflatable or semi-rigid	Definitive surgical treatment for refractory erectile dysfunction when injections fail or are contraindicated.
`53855`	Removal of penile prosthesis	May be performed if a prior penile implant causes complications and subsequent management includes injections or alternative therapy.

OpenPayer